JBIOJade Biosciences, Inc.同业对比
Jade Biosciences, Inc. 与SIC 2834 行业的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 | 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| JBIO本股 | $962M#7 | 2.3x#1 | 3.2x#7 | — | — | -83.0%#11 | — | -43.0%#9 | — | — | 171.9%#2 | — |
| CRVS | $1.1B#1 | — | 4.5x#10 | — | — | 75.4%#3 | — | -6.4%#3 | — | — | — | — |
| WVE | $1.1B#2 | — | 2.4x#6 | 25.5x#6 | -60.5%#9 | -110.7%#12 | -504.1%#6 | -45.1%#10 | — | — | — | — |
| PCRX | $1.0B#4 | 200.8x#4 | 1.6x#3 | 1.4x#2 | 3.6%#3 | 107.0%#1 | 2.6%#2 | 1.1%#2 | 0.9%#2 | — | — | — |
| OLMA | $1.0B#5 | — | 2.1x#5 | — | — | -25.5%#8 | — | -33.8%#7 | — | — | — | — |
| OPK | $993M#6 | — | 0.8x#1 | 1.6x#3 | -14.9%#6 | -324.0%#13 | -19.3%#3 | -19058.1%#12 | -13.3%#3 | 4#2 | — | — |
| LXRX | $1.0B#3 | — | 5.1x#11 | 20.8x#5 | 60.2%#1 | 74.9%#4 | -98.2%#4 | -24.8%#5 | -22.8%#4 | — | — | — |
| JANX | $922M#9 | — | 1.0x#2 | 92.2x#7 | -5.6%#5 | -64.7%#10 | -1576.7%#7 | -12.1%#4 | — | — | — | — |
| AMPH | $867M#10 | 11.8x#3 | 1.9x#4 | 1.2x#1 | -1.7%#4 | -38.5%#9 | 19.5%#1 | 22.0%#1 | 12.5%#1 | 6#1 | -6.2%#4 | — |
| ANRO | $946M#8 | — | 3.9x#9 | — | — | -2.9%#7 | — | -26.0%#6 | — | — | — | — |
| VYNE | $838M#11 | — | 34.0x#12 | 1471.0x#8 | 13.8%#2 | 33.5%#6 | -5219.1%#8 | -107.5%#11 | — | — | — | — |
| OMER | $838M#12 | 10.1x#2 | — | 11.4x#4 | -34.0%#7 | 97.9%#2 | -166.4%#5 | — | -177.9%#6 | — | 199.2%#1 | — |
| GERN | $818M#13 | — | 3.6x#8 | 3451.2x#9 | -60.2%#8 | 52.2%#5 | -28938.8%#9 | -36.4%#8 | -24.5%#5 | — | 11.4%#3 | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-08-01。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议